Entecavir is indicated for the treatment of CHB in adults with compensated liver disease and evidence of active viral replication and either elevated ALT/aspartate aminotransferase (AST ...

Lamivudine Entecavir Adefovir D There is positive evidence of human fetal risk based on adverse-reaction data from investigational or marketing experience or studies in humans, but potential ...

The company’s lead program, DST-1308, is a long-acting injectable formulation of entecavir, an antiviral agent used in the treatment of chronic hepatitis B. By utilizing the Silica Matrix technology, ...

Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading inside a person’s body. Now, a new analysis shows that people taking NRTI ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

† Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, Sichuan University, Sichuan, People’s Republic of China ‡ Faculty of Life Sciences, The University of Manchester, ...